Literature DB >> 10694513

Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition.

H Schneider1, C E Rudd.   

Abstract

CTLA-4 is well documented in its negative regulation of T-cell proliferation. However, little is known regarding the signaling mechanisms induced by CTLA-4. CTLA-4 associates with the phosphatidylinositol 3-kinase, the phosphatase SHP-2 and the clathrin adaptor complexes AP-1 and AP-2. SHP-2 SH2 domain binding to CTLA-4 is unusual given the absence of a I/VxYxxI/V/L motif. Here, we demonstrate that the phosphorylation of CTLA-4 tyrosines (YVKM and YFIP) fails to allow for single or tandem SHP-2 SH2 domain binding. This was observed using wild-type and inactive SHP-2 as well as a construct with the isolated two SH2 domains. The phosphorylated YVKM and YFIP motifs therefore do not appear to represent novel binding motifs for SHP-2 SH2 domains. At the same time, we could confirm that SHP-2 can associate with CTLA-4 in murine T-cells indicating that the interaction between the phosphatase and CTLA-4 is an indirect event, possibly mediated by PI 3-kinase/SHP-2 binding. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694513     DOI: 10.1006/bbrc.2000.2234

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis.

Authors:  Je-Min Choi; Seung-Hyung Kim; Jae-Hoon Shin; Thomas Gibson; Byoung-Seok Yoon; Dong-Ho Lee; Seung-Kyou Lee; Alfred L M Bothwell; Jong-Soon Lim; Sang-Kyou Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-09       Impact factor: 11.205

2.  T cell activation is reduced by the catalytically inactive form of protein tyrosine phosphatase SHP-2.

Authors:  Baoxia Dong; Yubo Gao; Xuan Zheng; Guangxun Gao; Hongtao Gu; Xiequn Chen; Jinyi Zhang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 3.  Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.

Authors:  Hélène Bour-Jordan; Jonathan H Esensten; Marc Martinez-Llordella; Cristina Penaranda; Melanie Stumpf; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

4.  Melanoma exosomes deliver a complex biological payload that upregulates PTPN11 to suppress T lymphocyte function.

Authors:  Yueting Wu; Wentao Deng; Emily Chambers McGinley; David J Klinke
Journal:  Pigment Cell Melanoma Res       Date:  2017-03-07       Impact factor: 4.693

5.  Translocation of CD28 to lipid rafts and costimulation of IL-2.

Authors:  Ali Sadra; Tomas Cinek; John B Imboden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

Review 6.  Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors.

Authors:  Diwakar Davar; Hassane M Zarour
Journal:  Methods Mol Biol       Date:  2020

7.  Polymorphisms of PTPN11 coding SHP-2 as biomarkers for ulcerative colitis susceptibility in the Japanese population.

Authors:  Yukiko Narumi; Hajime Isomoto; Mizuho Shiota; Kayoko Sato; Shinji Kondo; Haruhisa Machida; Katsunori Yanagihara; Yohei Mizuta; Shigeru Kohno; Kazuhiro Tsukamoto
Journal:  J Clin Immunol       Date:  2009-01-22       Impact factor: 8.317

8.  Tyrosine 201 of the cytoplasmic tail of CTLA-4 critically affects T regulatory cell suppressive function.

Authors:  Melanie Stumpf; Xuyu Zhou; Shunsuke Chikuma; Jeffrey A Bluestone
Journal:  Eur J Immunol       Date:  2014-04-15       Impact factor: 5.532

9.  Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

Authors:  Brian T Fife; Kristen E Pauken; Todd N Eagar; Takashi Obu; Jenny Wu; Qizhi Tang; Miyuki Azuma; Matthew F Krummel; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2009-09-27       Impact factor: 25.606

Review 10.  CD28 and CTLA-4 coreceptor expression and signal transduction.

Authors:  Christopher E Rudd; Alison Taylor; Helga Schneider
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.